SCHEDULE OF CONVERTIBLE BONDS (Details) - Maius Pharmaceutical Co. Ltd [Member] - USD ($) |
Mar. 31, 2025 |
Sep. 30, 2024 |
|---|---|---|
| Restructuring Cost and Reserve [Line Items] | ||
| Total | $ 300,000 | |
| GOLDPOW INTERNATIONAL CORP [Member] | ||
| Restructuring Cost and Reserve [Line Items] | ||
| Total | $ 300,000 |
| X | ||||||||||
- Definition The portion of the carrying value of convertible subordinated debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. This form of debt can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder, and places a lender in a lien position behind debt having a higher priority of repayment upon liquidation of the entity's assets. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|